Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gantong Granules is a Traditional Chinese Medicine (TCM) formulation used primarily for the treatment of the common cold with wind-heat syndrome (CCWHS). It is designed to relieve symptoms such as fever, headache, sore throat, and cough. The granule formulation is administered orally and has been evaluated in clinical trials for its efficacy and safety in alleviating symptoms associated with upper respiratory tract infections. The mechanism of action is based on TCM principles—clearing heat, detoxifying, and relieving wind-heat—but specific molecular targets are not defined in Western pharmacological terms. Clinical studies have shown favorable effects on symptom relief with minimal side effects[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gantong Granules.